TMCnet News
Allergy & Asthma Network and Blue Marble Health Advance Digital Health Innovation with Evidence-Based Platform for Asthma Self-ManagementResults of pilot testing demonstrate high usability and strong potential to expand equitable access to asthma self-management education FAIRFAX, Va., March 27, 2026 /PRNewswire/ -- Allergy & Asthma Network, a national leader in patient-centered research and education, and Blue Marble Health, a digital health technology company, today announced the publication of new research in The Journal of Allergy and Clinical Immunology in Practice (JACI: In Practice) highlighting the development and usability of Blue Marble Health's innovative digital asthma self-management education platform, BREATHE (BRinging Exercise, Asthma Assessments, and TeacHing to Everyone). Asthma self-management education (ASME) is essential for achieving optimal disease control, yet the majority of adults with asthma do not receive it. Through this research, Allergy & Asthma Network and Blue Marble Health address this critical gap by advancing scalable, digital solutions designed to reach under-resourced communities and reduce health disparities. Using a rigorous, user-centered design approach, researchers developed and evaluated the BREATHE platform to meet the needs of adults with asthma, particularly those facing barriers to healthcare access, as well as healthcare providers (HCPs). The study included two phases:
The BREATHE platform integrates comprehensive asthma education with practical self-management tools, including:
The results underscore the leadership of Allergy & Asthma Network and Blue Marble Health in digital health innovation:
"This research reflects our commitment to leading patient-centered innovation and expanding access to essential asthma education," says De De Gardner, DrPH, Chief Research Officer at Allergy & Asthma Network. "BREATHE demonstrates how digital tools can empower patients, support clinicians, and advance health equity for communities historically underserved by traditional healthcare models." The BREATHE platform is currently being used in Allergy & Asthma Network's free Virtual Asthma Coaching Program, further extending its impact by providing personalized support to individuals managing asthma. "This research further validates what has always been at the heart of Blue Marble Health's approach: technology built?with?patients and clinicians, not just?for?them, produces platforms people actually want to use," Sheryl Flynn, PT, PhD, CEO of Blue Marble Health. "The strong usability and feasibility outcomes we achieved with our Health in Motion – BREATHE Platform give us tremendous confidence as we advance into our clinical trial, where we will rigorously test whether this person-centered design translates into meaningful health outcomes for adults living with asthma, especially those living in under-resourced communities." The research was funded by an NIH NHLBI SBIR award number R44HL137502 for the development of tools and platforms to improve the dissemination and implementation of evidence-based interventions for lung diseases and disorders. The content of the manuscript is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. About Allergy & Asthma Network About Blue Marble Health Citation Contact: Gary Fitzgerald
SOURCE Allergy & Asthma Network
|
